What question did this study set out to answer?

The aim is to review existing evidence regarding neuromodulation as a treatment for long COVID symptoms.

March 2, 2026Open Access

Transcranial stimulation as a possible therapeutic proposal in long COVID

Puntos clave

The aim is to review existing evidence regarding neuromodulation as a treatment for long COVID symptoms.
Critical review of current literature on neuromodulation techniques
Focus on neurological and mental health symptoms associated with long COVID
Analysis of therapeutic outcomes reported in existing studies
Neuromodulation shows potential in alleviating chronic fatigue and cognitive impairment
Evidence suggests significant improvements in mood disorders related to long COVID
Current findings support the need for further research into effective neuromodulation therapies

Resumen

The COVID-19 pandemic triggered an unprecedented global health crisis, with significant repercussions on the mental and neurological health of millions of individuals. Long COVID, characterized by persistent and debilitating symptoms, including chronic fatigue, pain, cognitive impairment, and mood swings, represents a substantial therapeutic challenge. In this context, neuromodulation emerges as a promising therapeutic strategy, offering new perspectives for the management of refractory neurological symptoms. This article aims to critically review the current evidence on the use of neuromodulation in patients with long COVID.

Me gusta

Guardar

Ver artículo completo

Cite This Study

Santos et al. (Fri,) studied this question.

synapsesocial.com/papers/69a528b3f1e85e5c73bf0363 https://doi.org/https://doi.org/10.3389/fresc.2026.1766757

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Me gusta

Guardar

Ver artículo completo